NDC11 00187065301
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00187-0653-01 | 00187-0653 |
| 00187-0653-1 | 00187-0653 |
| 00187-653-01 | 00187-653 |
| 0187-0653-01 | 0187-0653 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Duobrii | HALOBETASOL PROPIONATE AND TAZAROTENE | Bausch Health US, LLC | b3f0cdc0-69fd-43d1-baf2-d776a3a20715 | 2020-01-01 | Warnings, Adverse reactions | 0187-0653-01 0187-0653 00187065301 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.